A Phase 2, Randomized, Controlled, Multicenter, Evaluation of the Efficacy and Safety of Locally Administered HTX-011, HTX-002, or HTX-009 for Postoperative Analgesia Following Bunionectomy
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Bupivacaine/meloxicam (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 31 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Apr 2017.
- 31 Mar 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Mar 2017.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History